<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00109278</url>
  </required_header>
  <id_info>
    <org_study_id>V205C-010</org_study_id>
    <secondary_id>2005_016</secondary_id>
    <nct_id>NCT00109278</nct_id>
  </id_info>
  <brief_title>A Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED)</brief_title>
  <official_title>A Comparison of the Safety, Tolerability, and Immunogenicity of V205C Manufactured From the 2003 Measles Stock Seed With Recombinant Human Albumin (rHA) Versus Currently Licensed V205C Manufactured From the 1967 Measles Stock Seed With Human Serum Albumin (HSA) in Healthy Children 12 to 18 Months of Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to test the safety of a measles, mumps, and rubella study
      vaccine made from a new measles stock seed (a component of the vaccine made in 2003) with rHA
      (recombinant human albumin).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The duration of treatment is 6 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2004</start_date>
  <completion_date type="Actual">May 2005</completion_date>
  <primary_completion_date type="Actual">May 2005</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Antibody response rate to measles at 6 weeks postvaccination</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Geometric mean titers to measles by ELISA at 6 weeks postvaccination</measure>
  </secondary_outcome>
  <enrollment type="Actual">1100</enrollment>
  <condition>Measles</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>V205C, measles, mumps, and rubella virus vaccine live</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Comparator: Measles, Mumps, and Rubella Virus Vaccine Live</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy children 12 to 18 months of age.

        Exclusion Criteria:

          -  Previous receipt of measles, mumps, rubella and/or varicella vaccine.

          -  Prior infection or exposure to (within last 4 weeks) measles, mumps, rubella,
             varicella and/or zoster.

          -  Any medical condition that might interfere with the immune response to the given
             vaccines (including HIV infection and/or cancer) or has undergone immunosuppressive
             (weakens your body's ability to fight infection) therapy.

          -  History of seizures (convulsions)

          -  Allergies to any component of the vaccine, including sorbitol, gelatin, or neomycin.

          -  A recent (within the last 3 days) illness resulting in a fever (underarm temperature
             greater than 99.5° F [37.5° C]).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Months</minimum_age>
    <maximum_age>18 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Monitor</last_name>
    <role>Study Director</role>
    <affiliation>Merck Sharp &amp; Dohme Corp.</affiliation>
  </overall_official>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2005</study_first_submitted>
  <study_first_submitted_qc>April 25, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 26, 2005</study_first_posted>
  <last_update_submitted>March 14, 2017</last_update_submitted>
  <last_update_submitted_qc>March 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prevention of Measles</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Measles</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <study_docs>
    <study_doc>
      <doc_type>CSR Synopsis</doc_type>
      <doc_url>http://www.merck.com/clinical-trials/policies-perspectives.html</doc_url>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

